American Century Companies’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
DCI
BB
American Century Companies's DFTX Position: Q1 2022 in Review
American Century Companies sold out of Definium Therapeutics (DFTX) in Q1 2022, closing a stake of 796 shares — an estimated $16K sold.
American Century Companies first reported a position in DFTX in Q3 2021 and held it in 2 quarters. The position peaked at $28K in Q3 2021. 159 funds tracked by Wall St. Rank hold DFTX as of Q1 2022.
- American Century Companies reported no remaining Definium Therapeutics position as of Q1 2022 after selling out during the quarter.
- American Century Companies sold 796 Definium Therapeutics shares in Q1 2022, an estimated $16K.
- American Century Companies first reported a position in Definium Therapeutics in Q3 2021 and held it in 2 quarters.
- American Century Companies's Definium Therapeutics position peaked at $28K in Q3 2021.
- 159 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2022.
Based on American Century Companies's 13F filing for Q1 2022, filed 11 May 2022.